BRIEF published on 05/13/2026 at 07:48, 4 months 30 days ago Rapport de performance financière de Dermapharm Holding SE pour le premier trimestre 2026 Résultats Financiers Acquisitions Croissance Des Revenus Médicaments De Marque Confirmation Des Directives
PRESS RELEASE published on 05/13/2026 at 07:43, 4 months 30 days ago Dermapharm Holding SE performs in line with projections in Q1 2026 and confirms guidance Dermapharm Holding SE reports Q1 2026 results: 1.1% revenue growth to EUR 305.8 million, EBITDA up 7.5% to EUR 87.4 million. Confirms guidance for 2026 EBITDA Revenue Growth Dermapharm Holding SE Q1 2026 2026 Guidance
BRIEF published on 03/31/2026 at 07:35, 6 months 12 days ago Dermapharm Holding SE prévoit des résultats financiers mitigés en 2025 Baisse Des Revenus Augmentation De L'EBITDA Croissance Des Produits Pharmaceutiques De Marque Stabilité Des Produits De Santé Dépôt D'importation Parallèle
BRIEF published on 03/31/2026 at 07:35, 6 months 12 days ago Dermapharm Holding SE sees mixed financial outcomes in 2025 Revenue Decline EBITDA Increase Branded Pharmaceuticals Growth Healthcare Products Stability Parallel Import Drop
PRESS RELEASE published on 03/31/2026 at 07:30, 6 months 12 days ago Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin Dermapharm Holding SE reports dip in revenue but rise in adjusted consolidated EBITDA and margin for the 2025 financial year, with expectations of further growth in 2026 Adjusted EBITDA Dermapharm Holding SE Revenue Dip Financial Year 2025 Margin Rise
BRIEF published on 03/26/2026 at 20:53, 6 months 17 days ago Dermapharm Executes Share Buyback Amid Strong Interest Share Buyback Financial Management Treasury Shares Stock Market Dermapharm
BRIEF published on 03/26/2026 at 20:53, 6 months 17 days ago Dermapharm procède à un rachat d'actions face à un fort intérêt Rachat D'actions Marché Boursier Gestion Financière Dermapharm Actions Du Trésor
PRESS RELEASE published on 03/26/2026 at 20:48, 6 months 17 days ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer. Company's buyback program exceeded maximum shares tendered. Offer price to be available by 2 April 2026 Share Buyback Treasury Shares Public Offer Dermapharm Holding SE Stock Repurchase
BRIEF published on 03/10/2026 at 09:16, 7 months 2 days ago Dermapharm Holding SE Announces Share Buyback Offer Share Buyback Dermapharm Holding SE Capital Measures 4,300,000 Shares EUR 42.00 Per Share
BRIEF published on 03/10/2026 at 09:16, 7 months 2 days ago Dermapharm Holding SE annonce une offre de rachat d'actions Rachat D'actions Dermapharm Holding SE Mesures De Capital 4 300 000 Actions 42,00 EUR Par Action
Published on 10/12/2026 at 22:01, 3 hours 9 minutes ago Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 10 hours 10 minutes ago Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 12 hours 10 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 20 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 23 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/12/2026 at 20:30, 4 hours 40 minutes ago Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 4 hours 40 minutes ago Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 5 hours 4 minutes ago SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 19:10, 5 hours 59 minutes ago Cell Impact announces acceleration of previously communicated order from US customer
Published on 10/12/2026 at 19:00, 6 hours 10 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 5 octobre 2026 au 9 octobre 2026
Published on 10/12/2026 at 17:59, 7 hours 10 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:59, 7 hours 10 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 7 au 9 octobre 2026
Published on 10/12/2026 at 17:45, 7 hours 25 minutes ago Déclaration des transactions sur actions propres réalisées du 05/10/2026 au 11/10/2026
Published on 10/12/2026 at 17:45, 7 hours 25 minutes ago Déclaration hebdomadaire de rachat d'actions
